DEcentralize Testing, Education, and Linkage to Care by Using Electronic Best Practice Advisory for Hepatitis B (DETECT-B)

Launched by VIETNAM VIRAL HEPATITIS ALLIANCE · May 3, 2024

Keywords

ClinConnect Summary

The DETECT-B trial is a study aimed at improving how we test for and treat Hepatitis B, a viral infection that affects the liver. Researchers want to see if a new approach, which includes better testing services and linking patients to care, can work well in a public healthcare setting. They will look at how effective this new model is in getting more people tested and treated, how well it is carried out, and the costs involved in implementing it.

Patients who visit Le Van Thinh Hospital's outpatient clinics during the study will be eligible to participate, especially those who agree to a quick test for Hepatitis B (called point-of-care HBsAg testing) during the last four months of the study. There are no specific exclusions for patients, meaning anyone coming to the clinic can potentially join. Healthcare providers and leaders involved in the outpatient department will also be part of the study if they consent to participate in interviews or focus groups. Overall, this trial is important because it aims to find better ways to help people get tested and treated for Hepatitis B, making care more accessible and effective.

Gender

ALL

Eligibility criteria

• • Inclusion criteria for patients
• • Patients who visit the outpatient clinics at Le Van Thinh Hospital during the study period.
• • Consent to use point-of-care HBsAg testing after being fully informed by the health care providers (this only applies during the last 4-month period where POC-HBsAg testing is introduced).
• • Exclusion criteria for patients: None
• • Inclusion criteria for healthcare providers and leaders
• • Healthcare providers who work in the outpatient department and are involved in the enhanced model during the 12-month implementation period.
• • Leaders who are involved in the enhanced model or make decisions or are authorized to to so relating to the enhanced model.
• • Consent to join the in-depth interview or focus group after being fully informed by the study investigators.
• • Exclusion criteria for healthcare providers and leaders: None